Online Monitoring Program to Prevent Flare-Ups in Cystic Fibrosis
Tests an online monitoring program to spot flare-ups early in people with cystic fibrosis.
Plain-language title generated from the registry record
Registry title: e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
Key facts
- Where
- Valencia, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with cystic fibrosis who have had no flare-ups in the last 30 days and can use an internet device with a camera and microphone.
- Age
- 6 years and older
- Sex
- All sexes can join
- Disease stage
- Diagnosed cystic fibrosis with no exacerbation (flare-up) in the last 30 days
- Earlier treatment
- People with a lung transplant, or on the waiting list for one, cannot join. Eye surgery in the last 3 months is also an exclusion.
Main reasons for not taking part
- Lung transplant or on the lung transplant waiting list
- Eye surgery in the last 3 months
- Hemothorax
- Active infection or inflammatory process
- Cognitive problems that make using telematic devices impossible
Read by machine on 9 November 2026.
Where in Spain
- Instalaciones de la Universitat de ValenciaValencia, SpainContact: Francisco Martinez Arnau, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Valencia
- Trial code
- NCT06313827
- Record updated
- 13 February 2025
- Original description
The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life.Read full original descriptionShow less
Effectiveness of an e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population: a Randomized Clinical Trial
The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life.
Participants will be assigned to one of 3 study groups:
Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus telematic control of exacerbations with feedback from the physiotherapist.
Inclusion: Diagnosed cystic fibrosis; Family access to an internet-enabled device; Camera and microphone; Absence of exacerbations in the last 30 days.
Exclusion: Patients with lung transplant or on the waiting list for lung transplantation; Previous eye surgery (3 months); Active infection or inflammatory process; Hemothorax; Tumors; Cognitive problems that make it impossible for them to use telematic devices.